TD Asset Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.54M Hold
144,772
﹤0.01% 994
2025
Q1
$1.64M Hold
144,772
﹤0.01% 1010
2024
Q4
$1.52M Hold
144,772
﹤0.01% 1063
2024
Q3
$1.51M Hold
144,772
﹤0.01% 1114
2024
Q2
$1.48M Buy
+144,772
New +$1.48M ﹤0.01% 1079